Accurate Discount Reallocation: Successfully Maintaining Compliance with Product Bundling
Product bundling represents an important sales strategy for pharmaceutical companies looking to extend distribution and accelerate revenue growth. But maintaining GP compliance requires complex calculations that quickly grow unmanageable as transaction volumes rise. Rather than risking errors or facing compliance fines, many companies avoid bundling altogether, foregoing the additional profits from this lucrative sales strategy. This session will focus on the discount reallocation process, which enables manufacturers to implement creative bundled sales strategies that maximize revenue while ensuring government pricing compliance.